BRIEF-Cytokinetics announces start of Phase 2 clinical trial of Omecamtiv Mecarbil
* Cytokinetics announces start of phase 2 clinical trial of Omecamtiv Mecarbil in Japanese subjects with heart failure Source text for Eikon: Further company coverage:
No comments:
Post a Comment